Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1999; 34:1644-1651
© 1999 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koba, S.
Right arrow Articles by Benedict, C. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koba, S.
Right arrow Articles by Benedict, C. R.

EXPERIMENTAL STUDIES

Vascular smooth muscle proliferation

Synergistic interaction between serotonin and low density lipoproteins

Shinji Koba, MD*, Rajbabu Pakala, PhDa, Takuya Watanabe, MD*, Takashi Katagiri, MD* and Claude R. Benedict, MD, DPhil, FACCa

a Department of Internal Medicine, Division of Cardiology, University of Texas Health Science Center at Houston, Houston, Texas, USA
* Showa University School of Medicine, Tokyo, Japan

Manuscript received September 21, 1998; revised manuscript received May 18, 1999, accepted June 28, 1999.

Reprint requests and correspondence: Dr. Claude R. Benedict, Department of Internal Medicine, Division of Cardiology, The University of Texas Health Science Center, 6431 Fannin, MSB 6.039, Houston, Texas 77030

OBJECTIVES

The purpose of this study was to examine whether low density lipoproteins (LDLs) or mildly oxidized LDL (mox-LDL) are mitogens for vascular smooth muscle cells (VSMCs) and whether they can act synergistically with serotonin (5HT), a known mitogen for VSMC, in potentiating the proliferative effect of 5HT on VSMC.

BACKGROUND

Whether LDL or mox-LDL has a mitogenic effect on VSMC has been controversial. It is possible that LDL may not be mitogenic to VSMC but modification of LDL may confer mitogenic properties on LDL. A known mitogen for VSMC is 5HT that is released by aggregating platelets at sites of atherosclerotic changes or endothelial dysfunction. It is possible that LDL may interact with 5HT to enhance VSMC proliferation induced by 5HT.

METHODS

Growth arrested primary VSMCs were incubated with different concentrations of LDL or mox-LDL for 24 h followed by incubation with 5HT for another 24 h (mild oxidation of LDL was achieved by incubating LDL with Cu++ which increased the thiobarbituric acid product formation without a change in electrophoretic mobility). The increase in cell number or the amount of 3H-thymidine incorporated into the DNA was then measured.

RESULTS

Low density lipoprotein and mox-LDL induced significant VSMC proliferation by themselves and this effect was potentiated by 5HT. The 5HT2 receptor antagonist (LY281067) and pertussis toxin reversed only the proliferative effect of 5HT. Polyinosinic acid (poly-I), an inhibitor of scavenger receptors, did not inhibit the proliferative effect of LDL or mox-LDL or their synergistic interaction with 5HT.

CONCLUSIONS

These results suggest that LDL and mox-LDL act synergistically with 5HT in inducing VSMC proliferation. The synergistic interaction could be blocked by LY281067 and pertussis toxin but not by poly-I acid.

Abbreviations and Acronyms
  BSA = bovine serum albumin
  DMEM = Dulbecco’s modified Eagle’s medium
  EDTA = ethylenediamine tetraacetic acid
  FBS = fetal bovine serum
  HBSS = Hank’s balanced salt solution
  JNK/SAPK = c-Jun N-terminal kinases/stress activated kinase
  LDL = low density lipoprotein
  Lyso-PC = lysophosphatydilcholine
  MAP-kinase = mitogen activated protein kinase
  mox-LDL = mildly oxidized low density lipoprotein
  PBS = phosphate buffered saline
  poly-I = polyinosinic acid
  PTX = pertussis toxin
  SMC = smooth muscle cell
  TBARS = thiobarbituric acid reactive products
  VSMC = vascular smooth muscle cell
  5HT = serotonin




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. E. Zettler, M. A. Prociuk, J. A. Austria, G. Zhong, and G. N. Pierce
Oxidized Low-Density Lipoprotein Retards the Growth of Proliferating Cells by Inhibiting Nuclear Translocation of Cell Cycle Proteins
Arterioscler Thromb Vasc Biol, April 1, 2004; 24(4): 727 - 732.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. E. Zettler, M. A. Prociuk, J. A. Austria, H. Massaeli, G. Zhong, and G. N. Pierce
OxLDL stimulates cell proliferation through a general induction of cell cycle proteins
Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H644 - H653.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
I. GOUNI-BERTHOLD and A. SACHINIDIS
Does the coronary risk factor low density lipoprotein alter growth and signaling in vascular smooth muscle cells?
FASEB J, October 1, 2002; 16(12): 1477 - 1487.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. V. Anderson, J. McNatt, F. J. Clubb, M. Herman, J.-P. Maffrand, F. DeClerck, C. Ahn, L. M. Buja, and J. T. Willerson
Platelet Inhibition Reduces Cyclic Flow Variations and Neointimal Proliferation in Normal and Hypercholesterolemic-Atherosclerotic Canine Coronary Arteries
Circulation, November 6, 2001; 104(19): 2331 - 2337.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Watanabe, R. Pakala, S. Koba, T. Katagiri, and C. R. Benedict
Lysophosphatidylcholine and Reactive Oxygen Species Mediate the Synergistic Effect of Mildly Oxidized LDL With Serotonin on Vascular Smooth Muscle Cell Proliferation
Circulation, March 13, 2001; 103(10): 1440 - 1445.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement